Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day Transcript

AI Briefing

• – Mesoblast Limited presents its cellular medicine platforms and innovations
• – The company discusses its research and development efforts in regenerative medicine
• – Paul Hughes shares insights on the future of cellular therapies